4//SEC Filing
Gilde Healthcare Holding B.V. 4
Accession 0001193125-25-243899
CIK 0001840748other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 6:58 PM ET
Size
11.4 KB
Accession
0001193125-25-243899
Insider Transaction Report
Form 4
Transactions
- Sale
Common Shares
2025-10-17$1.47/sh−1,181,131$1,736,263→ 2,947,781 total - Sale
Common Shares
2015-10-20$1.46/sh−1,000,000$1,460,000→ 1,947,781 total - Sale
Common Shares
2025-10-16$1.49/sh−690,239$1,028,456→ 4,128,912 total
Gilde Healthcare Holding B.V.
10% Owner
Transactions
- Sale
Common Shares
2025-10-17$1.47/sh−1,181,131$1,736,263→ 2,947,781 total - Sale
Common Shares
2025-10-16$1.49/sh−690,239$1,028,456→ 4,128,912 total - Sale
Common Shares
2015-10-20$1.46/sh−1,000,000$1,460,000→ 1,947,781 total
Footnotes (4)
- [F1]This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
- [F2]The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.
- [F3]This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
- [F4]This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Documents
Issuer
LAVA Therapeutics NV
CIK 0001840748
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001420106
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 6:58 PM ET
- Size
- 11.4 KB